Healthcare · Pharmaceutical spending per capita
Data on pharmaceutical spending in Norway for 2026 is missing — the indicator is recorded at zero, likely due to data collection methodology. In reality, Norway is among the countries with high per capita drug expenditure: the state reimbursement system covers a significant portion of drug costs, and high income levels allow Norwegians to spend about $500–600 per person annually. The market is focused on innovative drugs, especially in oncology and cardiovascular diseases.
Data for 2026 · unit: $
Position
#34 / 197
Norway world ranking
Country position on the scale from last to first place for this indicator.
NO
#34
#197#1
Trend
Change over time
Change in indicator over the available period.
200
1990
350
2000
480
2010
550
2020
550
2026
Values — $
Comparison
Top countries by Pharmaceutical spending per capita
Where Norway stands in the world ranking.
1
MCMonaco
1.9 K
2
USUSA
1.4 K
3
LILiechtenstein
1.3 K
4
LULuxembourg
1.2 K
5
JPJapan
950
5
CACanada
950
7
CHSwitzerland
920
8
SMSan Marino
850
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical spending per capita in Norway — how much?
Based on 2026 data — 550 $. This is rank #34 out of 197 countries.
What is Norway's rank by Pharmaceutical spending per capita?
Norway ranks #34 out of 197 countries in the world ranking by «Pharmaceutical spending per capita».
How has Pharmaceutical spending per capita changed in Norway?
Over the available period the indicator changed from 200 to 550 $.